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Several reports (1-3) where large molecular weight natural-occurring antigens 
and markedly heterogeneous antigenic material were used have demonstrated a 
statistically significant relationship of genetic factors to the immune response. 
More recently Levine, Ojeda, and Benacerraf (4, 5) have been able to demon- 
strate a genetic control of the immune response of guinea pigs immunized with 
hapten-poly-L-lysine conjugates. 
Previous evidence (6)  from this laboratory demonstrated that rabbits  and 
guinea  pigs  produce  insulin  antibodies  toward  several  determinants  on  the 
insulin molecule. The portions of the insulin molecule toward which antibodies 
were produced appeared to be an individual characteristic which varied from 
animal to animal.  It was therefore postulated that genetic factors controlled 
insulin  antibody production.  Supporting  evidence  (7)  for genetic control  of 
insulin  antibody production  demonstrated  that  inbred  strain  2  guinea  pigs 
produced antibodies to portions of beef insulin to which strain 13 guinea pigs 
could not produce antibodies. 
Additional supporting evidence that genetic factors control the configuration 
of the combining sites of insulin antibodies produced by guinea pigs is presented 
in this communication. Data consistent with the possibility that control of the 
antibody-combinlng site configuration may involve more than one gene and not 
multiple alleles at a given gene locus is also presented. 
Methods  and  Materials 
Antigens.-- 
lmsulin: Two preparations of insulin were used in these studies. Lilly insulin (Lot 917106)  1 
was a preparation of zinc crystals of beef insulin with a potency of 27.0 units/mg.  Novo 
insulin (Lot 03355)  2 was a commercial  preparation~  of 10 times recrystallized  beef insulin with 
a biological potency of 22.0 units/mg. 
* Presented in part before  the 49th Annual Meeting of the Federation of American  Societies 
for Experimental Biology,  April 9 through 14, 1965. (abstract, Fed. Proc., 1965, 24, 181). 
Supported by United States Public Health Service Grant A6001 and a grant-in-aid from 
Eli Lilly and Company, Indianapolis. 
x We wish to thank Dr. Otto K. Behrens, Eli Lilly and Company, Indianapolis, for the 
generous supply of crystalline beef insulin. 
2 We wish to thank Mr. H. Juncher, Novo Industri A/S, Copenhagen, Denmark, for the 
generous supply of 10 X crystalline beef insulin. 
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Alum-precipitated insulin (API) was prepared by suspending 50 mg insulin in 10 ml buffered 
saline (0.01  ~  phosphate buffer pH 7.4) and then adding 0.5  ml of  i  per cent alum, A1NH4 
(SO4)2"  12HiO. 
Insulin in Freund's adjuvant was prepared by adding 1.5 mI (7.5 rag) API to 10 mi Freund's 
complete adjuvant (Hyland Laboratories, Los Angeles). 
Antisera.-- 
Guinea  p4g antlsera to novo Snsulin:  Antisera to novo insulin were developed in adult male 
and female guinea pigs by injecting 0.2  ml insulin in Freund's adjuvant into each paw pad. 
They were desensitized 3 to 4 weeks  later by the  successive subcutaneous  injections of  1, 
10, and  100 vg API at 45 minute intervals and a second 100/~g API 1 hour later. The animals 
were constantly watched and 0.5 ml of 1:100,000  epinephrine was injected intraperitoneally 
when symptoms of anaphylaxis appeared. Following each series of inoculations, 4 ml of 50 per 
cent glucose was given intraperitoneally to minimize hypoglycemic reactions. 
One week following the desensitization procedure 7 to 10 ml samples of blood were taken 
by cardiac puncture.  Fourteen and  21  days posteardiae puncture  the animals were again 
desensitized. Between 28 and 31 days postcardiac puncture, the animals were again bled. In 
this manner, 3 to 5 ml of antiserum were obtained from each animal at monthly intervals. 
Blood samples were allowed to stand at room temperature, 25°C,  2 hours and then over- 
night  at 4°C.  The following morning  the  serum was  separated  by centrifugafion  (3000 g, 
10 minutes at 3°C), divided into aliquots, tested for antibody activity, and stored at  -80°C 
until used.  Complement activity of all anfisera was inactivated  by incubation at 56°C for 
30 minutes prior to being used. 
Animals.--The inbred strain 2 (str 2),  strain 13 (str 13), and F1 hybrids (str 2 X  str 13) 
were received from several sources3 The FI hybrids (Fx X  FI) were raised in our laboratory. 
The inbred  animals,  in all cases,  originally came from the  National Institutes  of Health, 
Bethesda,  Maryland; however, because of breeding difficulties,  many of these animals were 
not strictly offspring from brother-sister matings. Consequently, there may have been some 
errors due to breeding of which we were not aware. 
The partially inbred rabbits  (AO1 and AO2) were obtained from Jackson Memorial Lab- 
oratories, Bar Harbor, Maine. They are the strain III albino rabbits which, at the time, had 
a coefficient of inbreeding of approximately 0.70. These animals were immunized as previously 
described (6). 
Solutions.-- 
Veronal-buffered  saline  (VBS): The diluent used for complement and immune hemolysis 
titrations was veronal-buffered saline,  pH 7.4  (8),  containing 5  X  10-4M MgCI~ and  1.5 X 
10  -8 ~  CaCI~. 
Insulin: The insulin solution was made up at a concentration of 1 rag/rot. Insulin was dis- 
solved in 0.01 ~ NaOH, equal to one-half the desired final volume, and diluted to final volume 
with 0.22 ~a phosphate buffer, pH 7.4. This stock insulin solution was stored at 4°C and dis- 
carded if not used within 3 days. 
Complement: Adsorbed complement (Cta) was used for the hemolytic titration of antibodies. 
Pools of fresh guinea pig sera were adsorbed  at room temperature  (25  ° C) for 10 minutes, 
while gently agitated, with 10 mg/ml of the sheep erythrocyte stroma prepared according to 
3 The authors are grateful to Dr. Charles W. McPherson, D.V.M., Chief, Animal Produc- 
tion Section of National Institutes of Health, Bethesda, Maryland, Dr. Roy Walford, Depart- 
ment of Pathology, University of California, at Los Angeles School of Medicine, Los Angeles, 
and Dr. Charles Coehrane, Division of Experimental Pathology, Scripps Clinie and Research 
Foundation,  La Jolla, California, for supplying  the majority of the animals used in these 
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o  !  the method of Eylar a  a]. (9). It was divided into 2 ml aliquots and stored at --80 C. Ca prepa- 
rations maintained their complement activity for at least  6  months  when prepared in this 
manner, 
•  °  °  p  •  °  Titration of complement (10): Tlters of Ca were determined by 50 per cent hemolytic end 
points. A unit of complement is defined as the smallest amount of Ca which will cause lysls of 
50 per cent of the sensitized cells (1 ml of a 1.25 per cent suspension) in a final volume of 1.5 ml 
after 30 minutes at 37°C. 
Erythrocyte preparation: Sheep red cells were stored as sheep blood collected in an equal 
volume of Alsever's solution (11). This suspension was stored at 4°C and used for a period of 
14 days. 
Bis.diazo-bozz~ine  (BDB): BDB was prepared by a modification of the method described 
by Kabat and Mayer (12). To prepare approximately 200 ml stock BDB, 0.92 gm benzidlne 
and approximately 6.8 ml sodium nitrite were used. The reaction was carried out in the pres- 
ence of ice crystals. The final product was a pale yenow solution. This material was empirically 
standardized by adding 7 ml of 0.11 x¢ phosphate buffer pH 7.4 to 0.5 ml BDB (1:15 BDB). 
A  deep reddish brown color developed immediately and the solution became turbid within 
90 seconds (-i-S  seconds). In the event the solution did not immediately turn deep reddish 
brown, the onset of turbidity was also prolonged, A few crystals of benzidine were then added 
and the solution retested. When the turbidity developed rapidly (less than 80 seconds), small 
amounts of sodium nitrite were added  to  the solution. When the desired preparation was 
obtained, the  stock  BDB was  divided  into  0.S  ml  aliquots  and  stored  at  --80°C.  Under 
these conditions BDB was active for at least 9 months. 
Preparation of insulin-sensitized  erythrocyles (insulin cells): Insulin cells were prepared by 
conjugating  insulin to  the  surface  of  washed  sheep  erythrocytes with bis-diazo-benzidine, 
as previously described (13). 
Titration  of insulin antibody actldty:  Insulin antibodies were measured by a  modification 
of the immune hemolysis teehn{que pre.vlously described  (6). The hemolysis of insulin cells 
•  .  .  i  .  . 
by antibodies m the presence of excess Cs has been shown to be proportional to antibody con- 
centration with this method. Antisera, serially diluted with VBS to a final volume of 0.5 ml, 
were cooled in an ice bath and 20 50 per cent hemolytic  s  units of Ca in 0.3 ml were then added. 
Finally the cells (0.2  ml of a  2.5 per cent suspension) were added and evenly suspended by 
gentle shaking. All samples in a given experiment were incubated in a 370C water bath for 30 
minutes, the non-hemolyzed cells separated by centrifugation at 3°C at approximately 2000 g 
for 5 minutes, and the supernatant solutions decanted into 2 ml of water. The degree of hemol- 
ysis was measured by the extinction of each sample at 580 m/z with a  Beckman model DB 
spectrophotometer. 
By measuring the area of the hemolytic titration curve, it is possible to obtain precise 
measurements of relative antibody concentrations (6). The hemolytic titration curve areas 
obtained from 5  aliquots of  the same antiserum simultaneously tested were  estimated by 
planimetry. The standard deviation calculated from the mean area of the 5 aliquots was found 
to be :t:1.5 per cent. 
Preparation of insulin-cellulose (IC)  aggregate with BDB:  Insulin (60  rag) was  dissolved 
in 10 ml 0.01 ~ NaOH, to which 10 ml 0.22 ~  phosphate buffer pH 7.4 was then added. This 
solution was cooled in an ice bath and while constantly being stirred 0.5 ml of stock BDB was 
added.  Theoretically this should have resulted in equimolar concentrations of insulin and 
BDB assuming insulin to have a molecular weight of 6000. After 20 minutes incubation, 280 nag 
of PABC (p-aminobenzyl ether of cellulose) obtained from the California Corp. for Biochemi- 
eal Research, Los Angeles (cellex PAB) were added to the insulin-BDB solution. This mixture 
was incubated at 4°C for approximately 18 hours, with constant stirring. The PABC-BDB- 
insulin (IC) was then washed 6 times with distilled water. The washed IC was suspended in 
3.4 ml of VBS containing 150 mg per cent bovine serum albumin (VBS-alb) and stored at 4oC. 774  GENETIC  CONTROL  OF  INSULIN  ANTIBODIES 
To prepare the antibody-saturated insulin aggregate  (AB.-IC), 0.3 ml of the stock  IC was 
diluted with 15 ml of VBS-alb, centrifuged at approximately 2000 g for 10 minutes at 4°C, and 
the supematant discarded. Three aliquots (2 ml) of insulin antiserum were then successively 
incubated with IC for 15 minutes at room temperature while being shaken. Following the 
last incubation with the third aliquot of saturating antiserum and subsequent centrifugation, 
the AB,-IC was evenly suspended in 8 ml of VBS-alb, divided into eight 1 ml aliquots, cen- 
trifuged, and the supematants discarded. Diluted antisera (AB0 were added to the 8 ABa-IC 
aliquots to test for the presence of antibodies capable of binding to exposed antigenic deter- 
minants on the AB6-IC. 
RESULTS 
Experimental Procedure.--These  experiments were designed to test whether 
genetic factors control the configuration of the combining sites of insulin anti- 
bodies from inbred str 2, str  13  guinea pigs, the Fx (str 2 X  str  13),  and F, 
(F1  X  Fz) hybrids. 
Differences in  configuration of  the  insulin  antibody-combining sites  were 
discerned by measuring the percentage of antibodies in a test antiserum (AB0 
which bound to the exposed insulin determinants on an insoluble insulin com- 
plex (IC) which had been saturated with antibodies from a different antiserum 
(AB.). 
The detMls of this system have been previously described (6). 
In a  typical experiment an aliquot of stock insoluble insulin aggregate (IC) is saturated 
with antibodies from a  single antiserum (AB,) to form an insulin aggregate saturated with 
antibodies (AB,-IC). Aliquots of AB,-IC  (usually 8)  are each incubated with various test 
antisera (ABt). If a significant  percentage of antibodies in the ABt are bound to the AB,-IC 
it  is assumed  that the  test  antiserum contained antibodies which conformed to antigenic 
determinants  to  which  the  antibodies in AB,  could  not  conform.  Such  antibodies  were 
considered to have combining-site configurations different from any of the antibodies in AB,. 
The validity of these experiments requires that  the IC  be saturated with 
antibodies from the saturating antiserum (AB,) prior to the addition of the test 
antiserum AB,. In all experiments, saturation of IC with AB, was accomplished 
by repeatedly incubating IC with 3 fresh aliquots of ABe. In the vast majority 
of experiments the IC appeared to be saturated with insulin antibodies following 
the second incubation. The supernatant ABs aliquot following the third incuba- 
tion very rarely showed a  decrease in insulin antibodies. Saturation was not 
accomplished on two occasions when very low titered ABs was employed; these 
results were considered not valid. 
Theper cent binding of ABe to AB~-IC was calculated as previously described 
(6) from the difference in area under the curve obtained by the hemolytic titra- 
tion  of non-incubated  AB, with  the  area under  the  curve  obtained by  the 
hemolytic titration of ABt which had been incubated with ABs-IC. 
A  decrease of 10 per  cent or more of the  immune hemolysis titer of ABe 
which was incubated with AB,-IC was attributed to antibodies in AB, directed EDWARD  R.  ARQUILLA  AND  JACK  ~'INN  775 
to portions of the insulin molecule to which the  antibodies in the saturating 
antiserum (AB s) could not bind. An alternative possibility was the dissociation 
from AB~-IC of antibodies which had reduced ability or were less  capable of 
causing hemolysis of insulin cells.  Conceivably, antibodies in ABt could react 
with  those portions  of the  insulin  molecule from which  such  antibodies had 
TABLE I 
Similarity  in Combining Sites of Insulin Antibodies from Guinea Pigs of the Same 
Strain 
ABa 
Pool* 
C-1 
C-9 
C-17 
CB2 
Sir 2 
ABt 
C-12 
CB-2 
C-2 
C-3 
Pool* 
~t~d 
per cen~ 
0.5 
0.5 
0.5 
0.5 
0.5 
AB8 
Pools 
D-2 
D-7 
D-15 
D-32 
Str 13 
ABt 
D-22 
DB-2 
DB-3 
D-1 
D-3 
D-6 
POOl~ 
C-18 
C-19 
C-25 
C-26 
C-12 
0.5 
0.5 
0.5 
0.5 
0.5 
D-B2 
D-15 
D-24 
Pools 
ABt bound 
p~ffent 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
* This pool was a combination of approximately equal aliquots of antisera from 7 str 2 
guinea pigs. 
$ This pool was a combination of approximately equal aliquots of anfisera from 5 str 13 
guinea pigs. 
dissociated resulting in a  net decrease in the immune hemolysis fiter of incu- 
bated  ABt.  Evidence has  been  presented  (6)  demonstrating  that  decreased 
immune hemolysis titers of incubated AB, are not due to dissociation of insulin 
antibodies from AB~-IC during the period of incubation with the test antisera. 
Under these circumstances the following criteria were considered necessary 
to support the postulate that genetic factors control the configuration of the 
insulin antibody-combining sites in guinea pigs: 
1.  No differences in  configuration  of antibody-combining  site  should  be  demon- 
strable in guinea pigs of the same strain; i.e., str 2 ABt should not bind to str 2 AB,-IC 
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2.  Differences  in  configuration  of  antibody-combining  site  should  be  demon- 
strable  when antisera  from str 2 guinea pigs are compared to antisera from str  13 
guinea pigs. 
3.  Segregation  of such  differences  in  configuration of antibody-combining sites 
should be demonstrable when insulin antibodies from hybrid guinea pigs (Ft and F,) 
were compared to insulin antibodies from str 2 and str 13 parents. 
TABLE II 
Overlap of Combining Sites of Insulin Antibodies from Sir 2 and Str 13 Guinea Pigs 
Str 2  Str 13 ABt (9)*  Str 13 
ABa-  IC  No. Exp.  No. Bound~  ABs-IC 
6  14  0  6 
Str 2 AB  t  (9)* 
No. Exp.  No, Bound~ 
13  0 
* Designates the number of different antisera employed. 
:~ Designates the number of test antisera in which 10 per cent or more of the insulin anti- 
bodies bound to exposed antigenic sites on AB,-IC. 
TABLE III 
Configurational Differences  of Combining Sites of Insulin Antibodies Produced by S~r 2 (C) and 
Str 13 (D) Guinea Pigs 
Guinea pig AB t 
C/D$ 
C17/D15 
C18/D24 
C19/D32 
C25 
C26 
Per cent of ABt bound to ABB-IC saturated with: 
AOI* 
95/0 
70/O 
41/4 
3O/5 
26 
54 
AO2* 
99/0 
57/0 
35/0 
36/0 
23 
59 
* AO1 and AO2 are 2 different individual insulin  antisera  from partially  inbred  rabbits. 
:~ Str 2 (C) and Str 13 (D)  antiserum  pools previously described, see Table I. 
Similarity in Combining Sites of Insulin Antibodies Produced by Guinea Pigs 
of the Same Strains.--Table  I  summarizes  the results  observed in a  group of 
experiments  in  which  str  2  antisera  were  tested  against  insulin  aggregates 
saturated  with str 2  antibodies  and str  13  antisera were tested against insulin 
aggregates saturated with str 13 anfisera. 
Ten  experiments  were performed  testing  the  binding  of insulin  antibodies 
from 8 individual and 1 pooled str 2 anfisera (AB0 to insulin aggregates which 
had been saturated with antibodies from 4 individual and 1 pooled str 2 antisera 
(AB,-IC). None of the 9 str 2 test antisera (ABt) contained demonstrable anti- 
bodies with combining sites different than the antibodies in the 5 str 2 (Table I). EDWARD  R.  ARQUILLA  AND  JACK  FINN  777 
Likewise, in 10 experiments none of 9 test antisera (ABt) from str 13 guinea 
pigs contained significant amounts of insulin antibodies capable of binding to 
AB.-IC saturated with insulin antibodies from 6 str 13  (Table I). 
Because of the shortage of inbred animals it was necessary and also considered 
desirable to use a pooled str 2 and a pooled str 13 antiserum in these experi- 
ments. The str 2 pool was made up of approximately equal aliquots of antisera 
TABLE IV 
Combining Site Overlap of Insulin Antibodies  Produced  by F1 Offspring Compared  with Ant43odies 
Produced by Str 2 and Str 13 Guinea Pigs 
Fx ABt Cs. Str 2 ABs-IC 
Str  2  ABs 
Pool* 
CB2 
F~ ABt 
40 
41 
43 
44 
45 
46 
47 
48 
53 
41 
44 
45 
46 
AB  t-bound 
p~ c~t 
6.0 
0.5 
3.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
Fx ABt ¢~. Str 13 ABs-IC 
Str  13 ABs  Fx ABt  ABt-bound 
Pool:l:  40 
41 
4-3 
44 
45 
4.6 
47 
48 
53 
DB2  41 
44 
45 
46 
48 
cent 
0.5 
0.5 
0.5 
0.5 
0.5 
38.2*" 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
59.0.-- 
0.5 
*- Indicates significant binding. 
* This pool was a combination of approximately equal aliquots of antisera from 7 str 2 
guinea pigs. 
:~ This pool was a  combination of approximately equal aliquots of antisera  from 5  str 
13 guinea pigs. 
from 7 guinea pigs and the str  13 pool was made up of approximately equal 
aliquots of antisera from 5 guinea pigs. 
These experiments indicate that inbred guinea pigs of the same strain produce 
antibodies toward similar determinants on the insulin molecule. Consequently, 
it is probable that  the  configurations  of the  combining sites of insulin  anti- 
bodies produced by guinea pigs are similar in animals of the same strain. 
Configurational Differences  of Combining Sites of Insulin Antibodies from Sir 2 
and Str 13 Guinea Pigs.--Differences  in combining sites of insulin  antibodies 
from str  2  guinea pigs tested  against insulin  aggregates saturated  with  anti- 
bodies from str 13 guinea pigs could not be demonstrated. Nor were differences in 778  GENETIC  CONTROL  OF  INSULIN  ANTIBODIES 
combining sites of antibodies from str 13 guinea pigs noted when tested against 
ABs-IC saturated with antibodies from str 2 guinea pigs (Table II). 
In 14 experiments where 9 str 13 antisera were tested against insulin aggre- 
gates saturated with 6 different str 2 antisera, none of the str 13 antisera con- 
tained significant amounts of antibodies capable of binding to insulin aggre- 
gates saturated with antibodies from str 2 antisera. Likewise, in 13 experiments, 
with 9 str 2 AB,, no demonstrable antibodies were noted which were capable of 
binding to ABs-IC saturated with 6 str 13 ABe. Therefore, in 27 experiments, 
differences between str 2 and str 13 could not be demonstrated directly (Table 
II). 
Coniigurational differences of insulin antibody combining sites between str 2 
and str 13 guinea pigs were noted only when tested against 2 insulin aggregates, 
each saturated with antibodies from one of 2 partially inbred rabbits  (A01 and 
A02) Table III. In 12 experiments, each of 6 different str 2 antisera  contained 
antibodies which bound (25 to 95 per cent) to portions of the insulin molecule to 
which antibodies from neither of the 2 rabbits could bind. Whereas, in 8 experi- 
ments, none of the str 13 antisera contained significant (10 per cent or more) 
amounts of antibodies which could bind to either of the  2 insulin aggregates 
saturated with  antibodies from the partially inbred rabbits.  Therefore, str  2 
guinea pigs produce antibodies to portions of the insulin molecule to which str 13 
guinea pigs cannot produce antibodies. 
The results suggest that str 2 guinea pigs produce antibodies to antigenic 
sites on insulin which axe in close proximity to the binding sites of the antibodies 
produced by str 13 guinea pigs. The inability to demonstrate binding of anti- 
bodies from str 2 guinea pigs to insulin aggregates saturated with str 13 anti- 
bodies and vice versa is probably best explained by overlap of the respective 
antigenic determinants and interference due  to steric hindrance. The  deter- 
minants on insulin of antibodies from the partially inbred rabbits are probably 
in close proximity to the determinants of the antibodies from str 13 guinea pigs 
but more distant from the determinants of antibodies produced by str 2 guinea 
pigs.  Consequently, antibodies in AB, from str  13  animals did not  bind  and 
antibodies in AB, from str 2 animals did bind to AB~-IC saturated with anti- 
bodies from partially inbred rabbits. It therefore is likely that the configura- 
tions of the combining sites of a significant percentage of insulin antibodies in 
str 2 antisera are different than the configurations of the antibodies in str 13 
antisera. 
Combining Site Overlap of Insulin Antibodies Produced by F1 Offspring  Com- 
pared to Antibodies Produced  by Str 2 and Str 13 Guinea Pigs--Twenty-seven 
experiments employing 9 individual  F1  antisera  were done against  2 AB s-IC 
saturated with 2 str 2 ABB and also against 2 AB~-IC saturated with 2 str 13 
AB, (Table IV). One of the str 2 ABB was a pool made up of antisera from 7 
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animals. One Fx antiserum (46) contained significant amounts of antibodies with 
combining sites different  than the antibodies in both str  13 AB,.This same 
antiserum (46) did not contain insulin antibodies with combining sites different 
than the two str 2 AB,. One other FI animal (40)  contained (6 per cent)  a few 
(not significant)  antibodies which  combined  with insulin sites different from 
TABLE V 
Configurational 1)i.~erences of Combining Sites of Insulin Antibodies  Produced by Fl Animals 
Compared to Antibodies Produced ~  Str 2 and SI¢ 13 Guinea Pigs 
Fs ABt vs. Str 2 ABe-IC  F~ ABt 95. Str 13 ABe-IC 
Str 2 ABe  FI ABt  ABt-bound  ABt-bound 
Pool* 
C14 
62 
63 
64 
65 
66 
67 
61 
62 
63 
64 
~cen~ 
63.0<-- 
0.5 
~.0,-- 
0.5 
0.5 
0.5 
39.5<-- 
80.1.- 
0.5 
71.1.- 
Str 13 ABs  Fs ABt 
Pool*  62 
63 
65 
D15  61 
62 
63 
64 
D25  61 
62 
63 
64 
DB2  64 
~ber Ce~t 
42.2<-- 
3.5 
0.5 
1.6 
60.8*-- 
2.2 
99.0*- 
2.6 
75.1,- 
2.0 
88.7<-- 
39.0+- 
*- Indicates significant binding. 
* See footnotes  Table I. 
those saturated with str 2 antiserum pool. Therefore,  in  24 of 27 experiments, 
antibodies in the F1 antisera conformed to determinants on the insulin molecule 
in close proximity to the determinants with which the antibodies in str 2 or str 
13 antisera conformed. It is not known whether the significantly different com- 
bining sites of the antibodies in the one (46) F1 antiserum is a true characteristic 
of F1 antisera or whether an unrecognized error in breeding may have taken 
place.  It appears,  therefore, that  the great majority (possibly all)  of insulin 
antisera from F1 (str 2 X  str 13) hybrids do not contain discernable antibodies 
capable of binding to exposed determinants on insulin aggregates saturated with 
antibodies produced by str 2 or str 13 animals. Consequently, the configuration 
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from the configuration of antibody combining sites from str 2 and str 13 animal 
to be demonstrable in these experiments. 
Configurational Differences of Combining Sites  of Insulin Antibodies  Produced 
by F2 Animals Compared to Antibodies  Produced by Sir 2  and Str 13 Guinea 
Pigs.--Segregation of the differences in antibody-combining site configuration 
was noted when F2 (FIX  F1) antisera were tested against AB,-IC saturated 
with str 2 and str 13 antisera (Table V). Such differences were noted in 11 of 22 
experiments in  which  7 F2 ABt were tested against  2 str 2 AB,-IC and also 
against 4 str 13 AB,-IC (Table V). The pooled str 2 AB, and str 13 AB, used in 
TABLE VI 
Overlap of Insulin Antibody-Combining Sites of F1 and F~ Hybrid Crt~iftea .Pigs Compared to 
Antibody-Combining Sites of Rdated Animals 
Str. 2 ABt  (4)*  Str 13 ABt  (5)*  F, ABt  (6)* 
No. F, AB,-IC 
No.  FI  AB,-IC 
No. Exp.  No. Bound,~ 
7  0 
No. Str 2 ABt (4)* 
No. Exp.  No. Bound~ 
lO  o 
No. Exp.  No. Botmd$ 
7  0 
Str 13 ABt (4)* 
No. Exp.  No. Bound:~ 
10  I  0 
No. Exp.  No. Bounds 
11  I  0 
F, ABt (9)* 
J 
No. Exp.  l  No. Botmd~ 
18  I  0 
* Designates the number of different test antisera employed. 
Designates the number of test antisera in which 10 per cent or more of the insulin anti- 
bodies bound to exposed antigenic sites on AB~-IC. 
these  experiments were  aliquots  of the  same pooled antisera  previously de- 
scribed. 
Two (62 and 64) of the F, ABt contained a significant percentage of insulin 
antibodies with combining site configurations different from the antibodies in 
str 2 and also str 13 antisera. One (61)  of the F2 AB, contained insulin anti- 
bodies with combining site configurations different from the str 2 antibodies but 
similar to the str 13 antibodies.  The remaining 4  (63,  65-67) F, antisera con- 
tained insulin antibodies to determinants which overlapped the determinants to 
which the insulin  antibodies in both str 2 and str 13 AB, were directed. 
It appears therefore, that F2 offspring are capable of producing antibodies 
directed to portions of the insulin molecule to which neither of the inbred grand- 
parents can make antibodies. These findings, therefore, are consistent with the 
possibility that the configuration of the antibody-combining site in guinea pigs 
is controlled by more than one gene and not by different alleles at a given gene 
locus. 
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pared to Antibody-Combining  Sites of Related Animals.--The combining sites of 
insulin antibodies engendered in Ft (str 2 ×  str 13) guinea pigs were found to 
differ from the combining  sites of antibodies from inbred parents when the F1 
antisera were used to saturate insulln  aggregate (Table VI). Str 2 and str 13 
ABa overlapped most FI ABt (Table IV), and only half of the F2 ABt (Table 
V). In  these experiments,  4  different F~ ABcIC's were prepared  and  tested 
against 4 str 2, 5 str 13, and 6 F~ test antisera (ABe) in a total of 25 experiments, 
Table VI. Ft animals apparently produced antibodies which overlap or sterically 
hinder the binding of insulin antibodies from both inbred parents and also their 
hybrid offspring (F~). In this regard, the antibodies produced by F1 animals  are 
different  from  the  antibodies  produced by str  2  and  str  13  parents.  Most 
TABLE VII 
Insulin Antibody-ComMning Sites of FI and F~ Hybrld Guinea Pigs Compared to 
Antibody-Combining Sites from Other F1 and Fg. Animals Respeai~ely 
No. Fx AB~-IC 
FI ABt (9)* 
No. Exp.  No. Bound* 
19  i~ 
No. Ft ABs-IC 
F~ ABt (6)* 
No. Exp.  No. Bound* 
ix  2§ 
* See footnotes, Table VI. 
Antibodies (13 per cent) from F1 ABt (46) bound to AB,-IC saturated with F1 ABe (43). 
§ Antibodies (26 per cent) from F2 ABt  (64)  and also antibodies (21 per cent) from F~ 
ABt (67)  both bound to AB~-IC saturated with F~ AB~  (65). 
(possibly all) F1 animals produce antibodies which are not capable of binding to 
AB sic saturated with str 2 or str 13 AB, (Table IV). Whereas, about half of 
Fx animals produce antibodies capable of binding to ABs-IC saturated with str 2 
or str 13 AB~ (Table V). None of 6 F2 AB~ contained antibodies which bound to 
any of 4 Fl AB,-IC in 11 experiments (Table VI). It appears, therefore, that 
the Fx hybrid antibodies have combining  sites which conform to more determi- 
nants on the insulin  molecule than both of the inbred parents. However, the 
combining  sites  of  antibodies  produced  by  F~  animals  are  not  sufficiently 
different to be capable of binding to either str 2 or str 13 AB,-IC. 
A total of 38 experiments were performed with 5 F~ AB,-IC and ABt from 4 
str 2, 4 str 13, and 9 F1 guinea pigs (Table VI). The F~ antisera were capable of 
overlapping and preventing antibodies of all the ABt tested from reacting with 
antigenic sites on the insulin molecule. Since the F2 animals produce antibodies 
which react with both str 2 and str 13 AB~-IC (Table V), it would appear that 
F~ offspring can make antibodies which conform to a greater number of anti- 
genic sites on the insulin molecule than antibodies produced by F1 animals. 
It  appears,  therefore,  that  the variations  in  configurations  of the  insulin 
antibody-combining sites of F1 animals  are intermediate in comparison with F2 
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These  observations  are  considered  to be additional  evidence  that  genetic 
factors control the configuration  of the insulin  antibody-combining sites. 
Insulin Antibody-Combining Sites of F1 and F~ Hybrid Guinea Pigs Compared 
to Antibody-Combining Sites from Other F1 and F~ Animals Respectively.--Nine- 
teen experiments were performed in which  9 F1 AB, were tested against 4 FI 
AB,-IC. One F1 ABt (46) antiserum contained significant amounts of antibodies 
with  combining  site  configurations  different  than  the  F1  AB~  (43)  used  to 
saturate the IC (Table VII). It is interesting that this is the same and only Fx 
animal (46) whose antiserum contained significant  amounts of antibodies with 
combining site configurations  different than inbred str 13 animals  (Table IV). 
It is possible that the combining  site differences in the antibodies from this Fx 
(46)  guinea pig are a  true characteristic  of F1 antisera.  It is probably more 
tenable in view of the marked  disparity  with  respect to  all  the  other  8  F~ 
animals to tentatively explain the unique characteristics of Fx (46) antibodies as 
due to an unrecognized  error in breeding.  In which case it would be likely that 
the  configurations  of  the  combining  sites  of insulin  antibodies  amongst  Ft 
animals  are similar  to each  other.  It  is anticipated  that  with  additional  Fx 
animals this tentative explanation will be substantiated. 
Twelve experiments were performed where F2 antisera were compared with 
each other (Table VII). Two different AB, (F2 64 and 67) were found to have 
antibodies with combining  site confgurafions  different from one F~B,  (65). 
Such differences  were not demonstrable in the remaining  10 experiments.  In 
this regard, it is interesting that such differences were found in 4 of 21 experi- 
ments with mongrel guinea pigs (6). 
Much larger groups of Fx and F, n  nlmals must be tested to establish similarity 
of insulin antibody-combining sites amongst Fx animals and differences amongst 
F, animals.  With  the exception of one of the 31 experiments performed, the 
results  observed here are consistent with  the other results which  have been 
presented. 
DISCUSSION 
No configurational  differences  of antibody-combining sites  were  noted  in 
guinea pigs of the same strain  (Table I). Confignrational  differences in insulin 
antibody-combining sites  were  noted  between str  2  and  str  13  guinea  pigs 
(Table III). Segregation of differences in antibody combining site configurations 
was noted in FI and F2 guinea pigs (Tables V and VI).  It is  therefore,  quite 
probable  that  genetic factors  control  the  configuration  of insulin  antibody- 
combining sites in guinea pigs. 
Furthermore,  insulin  antibody-combining sites from  F2 animals  can  have 
configurations  that  are different from the configurations  of insulin  antibodies 
noted in either of the 2 inbred parental strains  (Table V). It is therefore also EDWARD  R.  ARQIHLLA  AND  JACK  FINN  783 
possible that  the configurations of the  combining sites  of insulin antibodies 
produced in guinea pigs is controlled by more than one gene and not by multiple 
alleles at a given gene locus. 
It is possible that these configuration differences of the F2 antibodies may be 
due to segregation of residual heterozygosity of the parental inbred str 2 and str 
13.  No  significant quantitative or  qualitative differences were noted within 
either of these strains (Table I). Consistent quantitative differences, however, 
were noted in the amounts of antibodies amongst the various str 2  AB~ that 
bound to both AB B-IC saturated with partially inbred rabbit antisera. Whether 
such quantitative differences are an expression of residual heterozygosity may 
possibly be  discerned by comparisons within and between different familial 
lines of the inbred str 2 and str 13 animals. 
Considerable evidence recently reviewed by Edelman and Gally (14) suggests 
that  the  configuration of  the  antibody-combining site  of  gG  is  formed by 
sequences of amino acids in contiguous portions of both the light (~) and heavy 
(5') chains. In which case, it would be likely that at least 2 genes are involved in 
dictating the configuration of the antibody-combining site of gG. 
The results presented here are in one way or another probably an expression 
of  all  the  immunoglobulins in  the  antisera  which  are  employed.  Sufficient 
animals have not been used to estimate the number of genes involved in deter- 
mining the configuration of the combining sites of the guinea pig insulin anti- 
bodies. It is therefore unwarranted to relate these results to the well documented 
(15) structure of human and rabbit gG. 
These  experiments  are  concerned  only with  the  binding  of  antibodies  to 
insulin. It would be presumptive therefore to speculate at which stage or stages 
of immunization the  gene or genes involved influence the  insulin antibody- 
combining site differences which have been demonstrated in these experiments. 
SUMMARy 
1. Genetic factors control the configuration of combining sites of guinea pig 
insulin antibodies. 
2. It is possible that the configuration of the combining sites of guinea pig 
insulin antibodies is controlled by more than one gene and not by multiple 
alleles at a given gene locus. 
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